Cresset Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.89M | Buy |
77,659
+5,893
| +8% | +$143K | 0.01% | 568 |
|
|
2025
Q1 | $1.49M | Buy |
71,766
+51,636
| +257% | +$1.07M | 0.01% | 627 |
|
|
2024
Q4 | $474K | Sell |
20,130
-3,696
| -16% | -$87K | ﹤0.01% | 1094 |
|
|
2024
Q3 | $610K | Sell |
23,826
-2,105
| -8% | -$53.9K | ﹤0.01% | 1382 |
|
|
2024
Q2 | $609K | Sell |
25,931
-2,077
| -7% | -$48.8K | ﹤0.01% | 1314 |
|
|
2024
Q1 | $806K | Sell |
28,008
-2,460
| -8% | -$70.8K | ﹤0.01% | 1071 |
|
|
2023
Q4 | $1,000K | Sell |
30,468
-192
| -0.6% | -$6.3K | 0.01% | 874 |
|
|
2023
Q3 | $854K | Sell |
30,660
-121
| -0.4% | -$3.37K | ﹤0.01% | 895 |
|
|
2023
Q2 | $1.05M | Buy |
+30,781
| New | +$1.05M | ﹤0.01% | 789 |
|
|
2022
Q3 | – | Sell |
-12,296
| Closed | -$387K | – | 885 |
|
|
2022
Q2 | $387K | Sell |
12,296
-133
| -1% | -$4.19K | ﹤0.01% | 635 |
|
|
2022
Q1 | $571K | Buy |
12,429
+2,122
| +21% | +$97.5K | 0.01% | 565 |
|
|
2021
Q4 | $631K | Buy |
10,307
+3,658
| +55% | +$224K | 0.01% | 618 |
|
|
2021
Q3 | $497K | Buy |
6,649
+1,210
| +22% | +$90.4K | 0.01% | 623 |
|
|
2021
Q2 | $503K | Sell |
5,439
-3,069
| -36% | -$284K | 0.01% | 550 |
|
|
2021
Q1 | $755K | Buy |
8,508
+2,910
| +52% | +$258K | 0.01% | 365 |
|
|
2020
Q4 | $522K | Buy |
5,598
+509
| +10% | +$47.5K | 0.01% | 383 |
|
|
2020
Q3 | $324K | Hold |
5,089
| – | – | 0.01% | 486 |
|
|
2020
Q2 | $265K | Buy |
+5,089
| New | +$265K | 0.01% | 505 |
|
|
2019
Q2 | – | Sell |
-250
| Closed | -$8K | – | 555 |
|
|
2019
Q1 | $8K | Buy |
+250
| New | +$8K | ﹤0.01% | 1222 |
|